These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 7601402)
41. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir. Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025 [TBL] [Abstract][Full Text] [Related]
42. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma. Tsuchiyama T; Kaneko S; Nakamoto Y; Sakai Y; Honda M; Mukaida N; Kobayashi K Cancer Gene Ther; 2003 Apr; 10(4):260-9. PubMed ID: 12679798 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes. Gerolami R; Cardoso J; Lewin M; Bralet MP; Sa Cunha A; Clément O; Bréchot C; Tran PL Cancer Res; 2000 Feb; 60(4):993-1001. PubMed ID: 10706115 [TBL] [Abstract][Full Text] [Related]
44. [Killing effect of adenovirus vector-mediated herpes simplex virus thymidine kinase gene recombinant construct on various cancer cells]. Zhou JF; Chen G; Lu YP; Wang SX; Ma D Ai Zheng; 2003 Dec; 22(12):1264-7. PubMed ID: 14693048 [TBL] [Abstract][Full Text] [Related]
45. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. Ezzeddine ZD; Martuza RL; Platika D; Short MP; Malick A; Choi B; Breakefield XO New Biol; 1991 Jun; 3(6):608-14. PubMed ID: 1655012 [TBL] [Abstract][Full Text] [Related]
46. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis. Agard C; Ligeza C; Dupas B; Izembart A; El Kouri C; Moullier P; Ferry N Cancer Gene Ther; 2001 Feb; 8(2):128-36. PubMed ID: 11263528 [TBL] [Abstract][Full Text] [Related]
47. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy. Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767 [TBL] [Abstract][Full Text] [Related]
48. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512 [TBL] [Abstract][Full Text] [Related]
49. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247 [TBL] [Abstract][Full Text] [Related]
54. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals. Su H; Lu R; Ding R; Kan YW Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975 [TBL] [Abstract][Full Text] [Related]
55. [Anti-tumor effect of adenovirus vector generated from homologous recombination of bacteria mediating TK gene on hepatic neoplasm cell]. Liu ZM; Yan LN Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):205-8. PubMed ID: 17441330 [TBL] [Abstract][Full Text] [Related]
56. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model. Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258 [TBL] [Abstract][Full Text] [Related]
57. Cell-specific induction of sensitivity to ganciclovir in medullary thyroid carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Minemura K; Takeda T; Minemura K; Nagasawa T; Zhang R; Leopardi R; DeGroot LJ Endocrinology; 2000 May; 141(5):1814-22. PubMed ID: 10803592 [TBL] [Abstract][Full Text] [Related]
58. Gene therapy of established medullary thyroid carcinoma with herpes simplex viral thymidine kinase in a rat tumor model: relationship of bystander effect and antitumor efficacy. Zhang R; DeGroot LJ Thyroid; 2000 Apr; 10(4):313-9. PubMed ID: 10807059 [TBL] [Abstract][Full Text] [Related]
59. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma. Goebel EA; Davidson BL; Graham SM; Kern JA Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985 [TBL] [Abstract][Full Text] [Related]
60. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene. Su H; Chang JC; Xu SM; Kan YW Hum Gene Ther; 1996 Mar; 7(4):463-70. PubMed ID: 8800740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]